| George Desilvester, MD | |
|
13000 N Meridian St Ste 101, Carmel, IN 46032-1404 | |
| (317) 848-1402 | |
| (317) 575-6912 |
| Full Name | George Desilvester |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 13000 N Meridian St Ste 101, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982798195 | NPI | - | NPPES |
| 100095450 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01035870 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Carmel | Carmel, IN | Hospital |
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Health Network Of Indiana Llc | 9830093533 | 212 |
News Archive
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
Microvi Biotech Inc., a leader in clean and waste-free water treatment technologies, today announced the completion of its first round of equity financing. The company plans to use the proceeds from the Series A financing to expand product development, grow the company's team, enhance the company R&D pipeline, and pave the way for the launch and commercialization of new, one-of-a-kind water technologies. The specific terms of the financing were not disclosed.
UCLA researchers have developed a lens-free microscope that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes.
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 6 days ago
| Entity Name | American Health Network Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831236272 PECOS PAC ID: 9830093533 Enrollment ID: O20031124000691 |
News Archive
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
Microvi Biotech Inc., a leader in clean and waste-free water treatment technologies, today announced the completion of its first round of equity financing. The company plans to use the proceeds from the Series A financing to expand product development, grow the company's team, enhance the company R&D pipeline, and pave the way for the launch and commercialization of new, one-of-a-kind water technologies. The specific terms of the financing were not disclosed.
UCLA researchers have developed a lens-free microscope that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes.
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Desilvester, MD 13000 N Meridian St Ste 101, Carmel, IN 46032-1404 Ph: (317) 848-1402 | George Desilvester, MD 13000 N Meridian St Ste 101, Carmel, IN 46032-1404 Ph: (317) 848-1402 |
News Archive
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
Microvi Biotech Inc., a leader in clean and waste-free water treatment technologies, today announced the completion of its first round of equity financing. The company plans to use the proceeds from the Series A financing to expand product development, grow the company's team, enhance the company R&D pipeline, and pave the way for the launch and commercialization of new, one-of-a-kind water technologies. The specific terms of the financing were not disclosed.
UCLA researchers have developed a lens-free microscope that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes.
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 6 days ago
Amanda Houchens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Sanju J Daftari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11911 N Meridian St, Suite 150, Carmel, IN 46032 Phone: 317-621-6701 Fax: 317-621-6707 | |
Rachel Land, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Heather Rae Schumann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Phone: 317-415-6900 | |
Robert D Habig, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15229 Westfield Blvd, Carmel, IN 46032 Phone: 317-867-1236 Fax: 317-896-1299 | |
Erica Dryden Leazenby, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy, Suite 104, Carmel, IN 46033 Phone: 317-415-6900 Fax: 317-415-6910 | |
Catherine E Broach, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Phone: 317-415-6900 |